84 results
Page 3 of 5
S-8
EX-99.1
2j9y5
27 Feb 20
Registration of securities for employees
12:00am
424B5
9er6yjhk2hkdsdh
9 Jan 20
Prospectus supplement for primary offering
5:25pm
8-K
EX-1.1
v3p4hh427xtk17hgty
9 Jan 20
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5:22pm
424B5
1ve4oh6x
7 Jan 20
Prospectus supplement for primary offering
4:19pm
S-3ASR
h1hknu 6g8t
7 Jan 20
Automatic shelf registration
4:01pm
S-3ASR
EX-4.3
xrc9k
7 Jan 20
Automatic shelf registration
4:01pm
S-3ASR
EX-4.4
slqw5gao 90txj6ny4v5
7 Jan 20
Automatic shelf registration
4:01pm
8-K
ux2 xwly5dvx6r0w
7 Oct 19
Departure of Directors or Certain Officers
4:06pm
8-K
EX-10.1
ae053yc nii
7 Oct 19
Departure of Directors or Certain Officers
4:06pm
POS AM
edor3
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm
POS AM
EX-1.2
tm5o9lpgw8nujxw61saa
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm
8-K
EX-4.1
je84d74wub1xc
16 Sep 19
Apellis Pharmaceuticals Announces Closing of Offering of Convertible Senior Notes
5:17pm